[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Asia Pacific Pharmacogenomics Market 2019-2025)

June 2019 | 103 pages | ID: A554A2C640FEN
KBV Research

US$ 1,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
The Asia Pacific Pharmacogenomics Market would witness market growth of 10.2% CAGR during the forecast period (2019–2025).

The study of pharmacogenomics deals with the role of genes in drug response in individuals. The growing number of pharmacogenomics-based tests, which are a result of the growing ailments like cancer, tuberculosis, Alzheimer's disease, cardiovascular diseases, and other diseases, is expected to push the market growth. Pharmacogenomics has observed an exponential growth rate in recent years, owing to a rise in preference of patients towards personalized therapy-based medications.

The major factors boosting the growth of pharmacogenomics include technological advancements in molecular diagnostics, such as several molecular biology techniques including polymerase chain reaction, sequencing, microarrays, electrophoresis, mass spectrometry among others, a surge in the preference for using personalized therapy.

Based on Technology, the market is segmented into Sequencing, Polymerase Chain Reaction, Electrophoresis, Mass Spectrometry, Microarray and Others. Based on Application, the market is segmented into Oncology, Psychiatry, Infectious Diseases, Neurological Diseases, Pain management, Cardiovascular Diseases and Others. Based on End User, the market is segmented into Hospitals and Clinics, Research Institutions, and Academic Institutes. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Empire Genomics LLC, Illumina, Inc., oneome LLC, Myriad Genetics Inc., Thermo Fisher Scientific, Inc., Teva Pharmaceuticals Industries Ltd., Bayer AG, Opko Health, Inc., and Becton, Dickinson and Company.

Scope of the Study

Market Segmentation:

By Application
  • Sequencing
  • Polymerase Chain Reaction
  • Electrophoresis
  • Mass Spectrometry
  • Microarray
  • Others
By Application
  • Oncology
  • Psychiatry
  • Infectious Diseases
  • Neurological Diseases
  • Pain management
  • Cardiovascular Diseases
  • Others
By End User
  • Hospitals and Clinics
  • Research Institutions
  • Academic Institutes
By Country
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
Companies Profiled
  • Abbott Laboratories
  • Empire Genomics LLC
  • Illumina, Inc.
  • Oneome LLC
  • Myriad Genetics Inc.
      • Thermo Fisher Scientific, Inc.
  • Teva Pharmaceuticals Industries Ltd.
  • Bayer AG
      • Opko Health, Inc.
  • Becton, Dickinson and Company
CHAPTER 1. MARKET SCOPE & METHODOLOGY

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
  1.4.1 Asia Pacific Pharmacogenomics Market, by Application
  1.4.2 Asia Pacific Pharmacogenomics Market, by Application
  1.4.3 Asia Pacific Pharmacogenomics Market, by End User
  1.4.4 Asia Pacific Pharmacogenomics Market, by Country
1.5 Methodology for the research

CHAPTER 2. MARKET OVERVIEW

2.1 Introduction
  2.1.1 Overview
  2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
  2.2.1 Market Drivers
  2.2.2 Market Restraints

CHAPTER 3. ASIA PACIFIC PHARMACOGENOMICS MARKET BY TECHNOLOGY

  3.1.1 Asia Pacific Sequencing Market by Country
  3.1.2 Asia Pacific Polymerase Chain Reaction Market by Country
  3.1.3 Asia Pacific Electrophoresis Market by Country
  3.1.4 Asia Pacific Mass Spectrometry Market by Country
  3.1.5 Asia Pacific Microarray Market by Country
  3.1.6 Asia Pacific Others Market by Country

CHAPTER 4. ASIA PACIFIC PHARMACOGENOMICS MARKET BY APPLICATION

  4.1.1 Asia Pacific Oncology Market by Country
  4.1.2 Asia Pacific Psychiatry Market by Country
  4.1.3 Asia Pacific Infectious Diseases Market by Country
  4.1.4 Asia Pacific Neurological Diseases Market by Country
  4.1.5 Asia Pacific Pain Management Market by Country
  4.1.6 Asia Pacific Cardiovascular Diseases Market by Country
  4.1.7 Asia Pacific Others Market by Country

CHAPTER 5. ASIA PACIFIC PHARMACOGENOMICS MARKET BY END USER

  5.1.1 Asia Pacific Hospitals and Clinics Market by Country
  5.1.2 Asia Pacific Research Institutions Market by Country
  5.1.3 Asia Pacific Academic Institutes Market by Country

CHAPTER 6. ASIA PACIFIC PHARMACOGENOMICS MARKET BY COUNTRY

6.1 China Pharmacogenomics Market
  6.1.1 China Pharmacogenomics Market by Technology
  6.1.2 China Pharmacogenomics Market by Application
  6.1.3 China Pharmacogenomics Market by End User
6.2 Japan Pharmacogenomics Market
  6.2.1 Japan Pharmacogenomics Market by Technology
  6.2.2 Japan Pharmacogenomics Market by Application
  6.2.3 Japan Pharmacogenomics Market by End User
6.3 India Pharmacogenomics Market
  6.3.1 India Pharmacogenomics Market by Technology
  6.3.2 India Pharmacogenomics Market by Application
  6.3.3 India Pharmacogenomics Market by End User
6.4 South Korea Pharmacogenomics Market
  6.4.1 South Korea Pharmacogenomics Market by Technology
  6.4.2 South Korea Pharmacogenomics Market by Application
  6.4.3 South Korea Pharmacogenomics Market by End User
6.5 Singapore Pharmacogenomics Market
  6.5.1 Singapore Pharmacogenomics Market by Technology
  6.5.2 Singapore Pharmacogenomics Market by Application
  6.5.3 Singapore Pharmacogenomics Market by End User
6.6 Malaysia Pharmacogenomics Market
  6.6.1 Malaysia Pharmacogenomics Market by Technology
  6.6.2 Malaysia Pharmacogenomics Market by Application
  6.6.3 Malaysia Pharmacogenomics Market by End User
6.7 Rest of Asia Pacific Pharmacogenomics Market
  6.7.1 Rest of Asia Pacific Pharmacogenomics Market by Technology
  6.7.2 Rest of Asia Pacific Pharmacogenomics Market by Application
  6.7.3 Rest of Asia Pacific Pharmacogenomics Market by End User

CHAPTER 7. COMPANY PROFILES

7.1 ABBOTT Laboratories
  7.1.1 Company Overview
  7.1.2 Financial Analysis
  7.1.3 Segmental and Regional Analysis
  7.1.4 Research & Development Expense
  7.1.5 Recent strategies and developments:
    7.1.5.1 Collaborations, partnerships and agreements:
    7.1.5.2 Product launches:
    7.1.5.3 Acquisition and mergers:
  7.1.6 SWOT Analysis
7.2 Empire Genomics LLC
  7.2.1 Company Overview
7.3 Illumina, Inc.
  7.3.1 Company Overview
  7.3.2 Financial Analysis
  7.3.3 Regional& Segmental Analysis
  7.3.4 Research& Development Expenses
  7.3.5 Recent strategies and developments:
    7.3.5.1 Collaborations, partnerships and agreements:
    7.3.5.2 Product launches:
    7.3.5.3 Acquisition and mergers:
7.4 OneOme LLC
  7.4.1 Company Overview
7.5 Myriad Genetics Inc.
  7.5.1 Company Overview
  7.5.2 Financial Analysis
  7.5.3 Segmental and Regional Analysis
  7.5.4 Research & Development Expense
  7.5.5 Recent strategies and developments:
    7.5.5.1 Collaborations, partnerships and agreements:
    7.5.5.2 Product launches:
7.6 Thermo Fischer Scientific, Inc.
  7.6.1 Company Overview
  7.6.2 Financial Analysis
  7.6.3 Segmental and Regional Analysis
  7.6.4 Research & Development Expense
  7.6.5 Recent strategies and developments:
    7.6.5.1 Collaborations, partnerships and agreements:
    7.6.5.2 Acquisition and mergers:
  7.6.6 SWOT Analysis
7.7 Teva Pharmaceuticals Industries Ltd.
  7.7.1 Company Overview
  7.7.2 Financial Analysis
  7.7.3 Segmental Analysis
  7.7.4 Research & Development Expense
  7.7.5 Recent strategies and developments:
    7.7.5.1 Product launches:
7.8 Bayer AG
  7.8.1 Company Overview
  7.8.2 Financial Analysis
  7.8.3 Segmental and Regional Analysis
  7.8.4 Research & Development Expense
  7.8.5 Recent strategies and developments:
    7.8.5.1 Collaborations, partnerships and agreements:
  7.8.6 SWOT Analysis
7.9 Opko Health, Inc. (GeneDx, Inc.)
  7.9.1 Company Overview
  7.9.2 Financial Analysis
  7.9.3 Research & Development Expense
  7.9.4 Recent strategies and developments:
    7.9.4.1 Collaborations, partnerships and agreements:
    7.9.4.2 Product launches:
7.1 Becton, Dickinson and Company
  7.10.1 Company Overview
  7.10.2 Financial Analysis
  7.10.3 Segmental and Regional Analysis
  7.10.4 Research & Development Expense
  7.10.5 Recent strategies and developments:
    7.10.5.1 Collaborations, partnerships and agreements:
    7.10.5.2 Acquisition and mergers:
    7.10.5.3 Product launches:
  7.10.6 SWOT Analysis

LIST OF TABLES

TABLE 1 ASIA PACIFIC PHARMACOGENOMICS MARKET, 2015 - 2018, USD MILLION
TABLE 2 ASIA PACIFIC PHARMACOGENOMICS MARKET, 2019 - 2025, USD MILLION
TABLE 3 ASIA PACIFIC PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 4 ASIA PACIFIC PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 5 ASIA PACIFIC SEQUENCING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 6 ASIA PACIFIC SEQUENCING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 7 ASIA PACIFIC POLYMERASE CHAIN REACTION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 8 ASIA PACIFIC POLYMERASE CHAIN REACTION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 9 ASIA PACIFIC ELECTROPHORESIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 10 ASIA PACIFIC ELECTROPHORESIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 11 ASIA PACIFIC MASS SPECTROMETRY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 12 ASIA PACIFIC MASS SPECTROMETRY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 13 ASIA PACIFIC MICROARRAY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 14 ASIA PACIFIC MICROARRAY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 15 ASIA PACIFIC OTHERS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 16 ASIA PACIFIC OTHERS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 17 ASIA PACIFIC PHARMACOGENOMICS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 18 ASIA PACIFIC PHARMACOGENOMICS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 19 ASIA PACIFIC ONCOLOGY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 20 ASIA PACIFIC ONCOLOGY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 21 ASIA PACIFIC PSYCHIATRY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 22 ASIA PACIFIC PSYCHIATRY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 23 ASIA PACIFIC INFECTIOUS DISEASES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 24 ASIA PACIFIC INFECTIOUS DISEASES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 25 ASIA PACIFIC NEUROLOGICAL DISEASES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 26 ASIA PACIFIC NEUROLOGICAL DISEASES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 27 ASIA PACIFIC PAIN MANAGEMENT MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 28 ASIA PACIFIC PAIN MANAGEMENT MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 29 ASIA PACIFIC CARDIOVASCULAR DISEASES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 30 ASIA PACIFIC CARDIOVASCULAR DISEASES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 31 ASIA PACIFIC OTHERS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 32 ASIA PACIFIC OTHERS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 33 ASIA PACIFIC PHARMACOGENOMICS MARKET BY END USER, 2015 - 2018, USD MILLION
TABLE 34 ASIA PACIFIC PHARMACOGENOMICS MARKET BY END USER, 2019 - 2025, USD MILLION
TABLE 35 ASIA PACIFIC HOSPITALS AND CLINICS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 36 ASIA PACIFIC HOSPITALS AND CLINICS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 37 ASIA PACIFIC RESEARCH INSTITUTIONS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 38 ASIA PACIFIC RESEARCH INSTITUTIONS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 39 ASIA PACIFIC ACADEMIC INSTITUTES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 40 ASIA PACIFIC ACADEMIC INSTITUTES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 41 ASIA PACIFIC PHARMACOGENOMICS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 42 ASIA PACIFIC PHARMACOGENOMICS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 43 CHINA PHARMACOGENOMICS MARKET, 2015 - 2018, USD MILLION
TABLE 44 CHINA PHARMACOGENOMICS MARKET, 2019 - 2025, USD MILLION
TABLE 45 CHINA PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 46 CHINA PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 47 CHINA PHARMACOGENOMICS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 48 CHINA PHARMACOGENOMICS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 49 CHINA PHARMACOGENOMICS MARKET BY END USER, 2015 - 2018, USD MILLION
TABLE 50 CHINA PHARMACOGENOMICS MARKET BY END USER, 2019 - 2025, USD MILLION
TABLE 51 JAPAN PHARMACOGENOMICS MARKET, 2015 - 2018, USD MILLION
TABLE 52 JAPAN PHARMACOGENOMICS MARKET, 2019 - 2025, USD MILLION
TABLE 53 JAPAN PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 54 JAPAN PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 55 JAPAN PHARMACOGENOMICS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 56 JAPAN PHARMACOGENOMICS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 57 JAPAN PHARMACOGENOMICS MARKET BY END USER, 2015 - 2018, USD MILLION
TABLE 58 JAPAN PHARMACOGENOMICS MARKET BY END USER, 2019 - 2025, USD MILLION
TABLE 59 INDIA PHARMACOGENOMICS MARKET, 2015 - 2018, USD MILLION
TABLE 60 INDIA PHARMACOGENOMICS MARKET, 2019 - 2025, USD MILLION
TABLE 61 INDIA PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 62 INDIA PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 63 INDIA PHARMACOGENOMICS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 64 INDIA PHARMACOGENOMICS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 65 INDIA PHARMACOGENOMICS MARKET BY END USER, 2015 - 2018, USD MILLION
TABLE 66 INDIA PHARMACOGENOMICS MARKET BY END USER, 2019 - 2025, USD MILLION
TABLE 67 SOUTH KOREA PHARMACOGENOMICS MARKET, 2015 - 2018, USD MILLION
TABLE 68 SOUTH KOREA PHARMACOGENOMICS MARKET, 2019 - 2025, USD MILLION
TABLE 69 SOUTH KOREA PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 70 SOUTH KOREA PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 71 SOUTH KOREA PHARMACOGENOMICS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 72 SOUTH KOREA PHARMACOGENOMICS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 73 SOUTH KOREA PHARMACOGENOMICS MARKET BY END USER, 2015 - 2018, USD MILLION
TABLE 74 SOUTH KOREA PHARMACOGENOMICS MARKET BY END USER, 2019 - 2025, USD MILLION
TABLE 75 SINGAPORE PHARMACOGENOMICS MARKET, 2015 - 2018, USD MILLION
TABLE 76 SINGAPORE PHARMACOGENOMICS MARKET, 2019 - 2025, USD MILLION
TABLE 77 SINGAPORE PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 78 SINGAPORE PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 79 SINGAPORE PHARMACOGENOMICS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 80 SINGAPORE PHARMACOGENOMICS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 81 SINGAPORE PHARMACOGENOMICS MARKET BY END USER, 2015 - 2018, USD MILLION
TABLE 82 SINGAPORE PHARMACOGENOMICS MARKET BY END USER, 2019 - 2025, USD MILLION
TABLE 83 MALAYSIA PHARMACOGENOMICS MARKET, 2015 - 2018, USD MILLION
TABLE 84 MALAYSIA PHARMACOGENOMICS MARKET, 2019 - 2025, USD MILLION
TABLE 85 MALAYSIA PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 86 MALAYSIA PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 87 MALAYSIA PHARMACOGENOMICS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 88 MALAYSIA PHARMACOGENOMICS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 89 MALAYSIA PHARMACOGENOMICS MARKET BY END USER, 2015 - 2018, USD MILLION
TABLE 90 MALAYSIA PHARMACOGENOMICS MARKET BY END USER, 2019 - 2025, USD MILLION
TABLE 91 REST OF ASIA PACIFIC PHARMACOGENOMICS MARKET, 2015 - 2018, USD MILLION
TABLE 92 REST OF ASIA PACIFIC PHARMACOGENOMICS MARKET, 2019 - 2025, USD MILLION
TABLE 93 REST OF ASIA PACIFIC PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 94 REST OF ASIA PACIFIC PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 95 REST OF ASIA PACIFIC PHARMACOGENOMICS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 96 REST OF ASIA PACIFIC PHARMACOGENOMICS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 97 REST OF ASIA PACIFIC PHARMACOGENOMICS MARKET BY END USER, 2015 - 2018, USD MILLION
TABLE 98 REST OF ASIA PACIFIC PHARMACOGENOMICS MARKET BY END USER, 2019 - 2025, USD MILLION
TABLE 99 KEY INFORMATION – ABBOTT LABORATORIES
TABLE 100 KEY INFORMATION - EMPIRE GENOMICS LLC
TABLE 101 KEY INFORMATION – ILLUMINA, INC.
TABLE 102 KEY INFORMATION – ONEOME LLC
TABLE 103 KEY INFORMATION – MYRIAD GENETICS INC.
TABLE 104 KEY INFORMATION – THERMO FISHER SCIENTIFIC, INC.
TABLE 105 KEY INFORMATION – TEVA PHARMACEUTICALS INDUSTRIES LTD.
TABLE 106 KEY INFORMATION – BAYER AG
TABLE 107 KEY INFORMATION – OPKO HEALTH, INC.
TABLE 108 KEY INFORMATION – BECTON, DICKINSON AND COMPANY

LIST OF FIGURES

FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 2 SWOT ANALYSIS: ABBOTT LABORATORIES
FIG 3 SWOT ANALYSIS: THERMO FISHER SCIENTIFIC, INC.
FIG 4 SWOT ANALYSIS: BAYER AG
FIG 5 SWOT ANALYSIS: BECTON, DICKINSON AND COMPANY


More Publications